Trial Profile
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Semaglutide (Primary) ; Levothyroxine sodium
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 18 Mar 2019 Results presented at the 101st Annual Meeting of the Endocrine Society
- 26 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Dec 2016 Status changed from recruiting to active, no longer recruiting.